185 related articles for article (PubMed ID: 1730924)
1. Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4.
Schockmel GA; Somoza C; Davis SJ; Williams AF; Healey D
J Exp Med; 1992 Jan; 175(1):301-4. PubMed ID: 1730924
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
[TBL] [Abstract][Full Text] [Related]
3. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).
Choe HR; Sodroski J
J Virol; 1995 May; 69(5):2801-10. PubMed ID: 7707502
[TBL] [Abstract][Full Text] [Related]
4. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.
Piatier-Tonneau D; Gastinel LN; Moussy G; Bénichou B; Amblard F; Vaigot P; Auffray C
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6858-62. PubMed ID: 1713692
[TBL] [Abstract][Full Text] [Related]
6. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
[TBL] [Abstract][Full Text] [Related]
7. CD4-Induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization.
Sullivan N; Sun Y; Sattentau Q; Thali M; Wu D; Denisova G; Gershoni J; Robinson J; Moore J; Sodroski J
J Virol; 1998 Jun; 72(6):4694-703. PubMed ID: 9573233
[TBL] [Abstract][Full Text] [Related]
8. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
9. Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules.
Bowman MR; MacFerrin KD; Schreiber SL; Burakoff SJ
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9052-6. PubMed ID: 1978941
[TBL] [Abstract][Full Text] [Related]
10. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
[TBL] [Abstract][Full Text] [Related]
11. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.
Lee S; Peden K; Dimitrov DS; Broder CC; Manischewitz J; Denisova G; Gershoni JM; Golding H
J Virol; 1997 Aug; 71(8):6037-43. PubMed ID: 9223495
[TBL] [Abstract][Full Text] [Related]
13. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
Healey D; Dianda L; Moore JP; McDougal JS; Moore MJ; Estess P; Buck D; Kwong PD; Beverley PC; Sattentau QJ
J Exp Med; 1990 Oct; 172(4):1233-42. PubMed ID: 1698911
[TBL] [Abstract][Full Text] [Related]
14. Role of CD4 epitopes outside the gp120-binding site during entry of human immunodeficiency virus type 1.
Simon JH; Stumbles P; Signoret N; Somoza C; Puklavec M; Sattentau QJ; Barclay AN; James W
J Virol; 1997 Feb; 71(2):1476-84. PubMed ID: 8995673
[TBL] [Abstract][Full Text] [Related]
15. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
[TBL] [Abstract][Full Text] [Related]
16. Fine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.
Pantophlet R; Ollmann Saphire E; Poignard P; Parren PW; Wilson IA; Burton DR
J Virol; 2003 Jan; 77(1):642-58. PubMed ID: 12477867
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication.
Kolchinsky P; Mirzabekov T; Farzan M; Kiprilov E; Cayabyab M; Mooney LJ; Choe H; Sodroski J
J Virol; 1999 Oct; 73(10):8120-6. PubMed ID: 10482561
[TBL] [Abstract][Full Text] [Related]
18. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
19. The genetic analysis of the HIV envelope binding domain on CD4.
Arthos J; Deen KC; Shatzman A; Truneh A; Rosenberg M; Sweet RW
Ann N Y Acad Sci; 1990; 616():116-24. PubMed ID: 2078013
[TBL] [Abstract][Full Text] [Related]
20. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection.
Simon JH; Somoza C; Schockmel GA; Collin M; Davis SJ; Williams AF; James W
J Exp Med; 1993 Apr; 177(4):949-54. PubMed ID: 8459222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
